301 related articles for article (PubMed ID: 29633103)
1. Vinpocetine Ameliorates Acetic Acid-Induced Colitis by Inhibiting NF-κB Activation in Mice.
Colombo BB; Fattori V; Guazelli CFS; Zaninelli TH; Carvalho TT; Ferraz CR; Bussmann AJC; Ruiz-Miyazawa KW; Baracat MM; Casagrande R; Verri WA
Inflammation; 2018 Aug; 41(4):1276-1289. PubMed ID: 29633103
[TBL] [Abstract][Full Text] [Related]
2. Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord.
Ruiz-Miyazawa KW; Zarpelon AC; Pinho-Ribeiro FA; Pavão-de-Souza GF; Casagrande R; Verri WA
PLoS One; 2015; 10(3):e0118942. PubMed ID: 25822523
[TBL] [Abstract][Full Text] [Related]
3. Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB.
Ruiz-Miyazawa KW; Pinho-Ribeiro FA; Zarpelon AC; Staurengo-Ferrari L; Silva RL; Alves-Filho JC; Cunha TM; Cunha FQ; Casagrande R; Verri WA
Chem Biol Interact; 2015 Jul; 237():9-17. PubMed ID: 25980587
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation.
Lourenco-Gonzalez Y; Fattori V; Domiciano TP; Rossaneis AC; Borghi SM; Zaninelli TH; Bernardy CCF; Alves-Filho JC; Cunha TM; Cunha FQ; Casagrande R; Verri WA
Mediators Inflamm; 2019; 2019():6481812. PubMed ID: 31049025
[TBL] [Abstract][Full Text] [Related]
5. Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats.
Alizadeh Nobakht NA; Lashgari NA; Momeni Roudsari N; Niknejad A; Khayatan D; Tavakoli S; Abdollahi AR; Esmaealzadeh N; Momtaz S; Abdolghaffari AH
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):92-103. PubMed ID: 37936449
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of cavidine on acetic acid-induced murine colitis via regulating antioxidant, cytokine profile and NF-κB signal transduction pathways.
Niu X; Zhang H; Li W; Wang Y; Mu Q; Wang X; He Z; Yao H
Chem Biol Interact; 2015 Sep; 239():34-45. PubMed ID: 26102009
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Impellizzeri D; Bruschetta G; Di Paola R; Ahmad A; Campolo M; Cuzzocrea S; Esposito E; Navarra M
Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
[TBL] [Abstract][Full Text] [Related]
8. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
9. Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation.
Quaglio AE; Castilho AC; Di Stasi LC
Life Sci; 2015 Nov; 141():179-87. PubMed ID: 26434698
[TBL] [Abstract][Full Text] [Related]
10. Febuxostat attenuates ulcerative colitis by the inhibition of NF-κB, proinflammatory cytokines, and oxidative stress in mice.
Amirshahrokhi K
Int Immunopharmacol; 2019 Nov; 76():105884. PubMed ID: 31499267
[TBL] [Abstract][Full Text] [Related]
11. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis.
Guazelli CFS; Fattori V; Ferraz CR; Borghi SM; Casagrande R; Baracat MM; Verri WA
Chem Biol Interact; 2021 Jan; 333():109315. PubMed ID: 33171134
[TBL] [Abstract][Full Text] [Related]
13. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
14. Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-κB activation in mice.
Fattori V; Borghi SM; Guazelli CFS; Giroldo AC; Crespigio J; Bussmann AJC; Coelho-Silva L; Ludwig NG; Mazzuco TL; Casagrande R; Verri WA
Pharmacol Res; 2017 Jun; 120():10-22. PubMed ID: 28315429
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
16. Fisetin, a dietary flavonoid, ameliorates experimental colitis in mice: Relevance of NF-κB signaling.
Sahu BD; Kumar JM; Sistla R
J Nutr Biochem; 2016 Feb; 28():171-82. PubMed ID: 26878795
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways.
Park S; Regmi SC; Park SY; Lee EK; Chang JH; Ku SK; Kim DH; Kim JA
Eur J Pharmacol; 2014 Jul; 735():184-92. PubMed ID: 24769511
[TBL] [Abstract][Full Text] [Related]
18. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
19. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
[TBL] [Abstract][Full Text] [Related]
20. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
